JP2015523388A5 - - Google Patents

Download PDF

Info

Publication number
JP2015523388A5
JP2015523388A5 JP2015524327A JP2015524327A JP2015523388A5 JP 2015523388 A5 JP2015523388 A5 JP 2015523388A5 JP 2015524327 A JP2015524327 A JP 2015524327A JP 2015524327 A JP2015524327 A JP 2015524327A JP 2015523388 A5 JP2015523388 A5 JP 2015523388A5
Authority
JP
Japan
Prior art keywords
formulation
spinosad
cat
tablet
felis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015524327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015523388A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/050987 external-priority patent/WO2014018352A1/en
Publication of JP2015523388A publication Critical patent/JP2015523388A/ja
Publication of JP2015523388A5 publication Critical patent/JP2015523388A5/ja
Withdrawn legal-status Critical Current

Links

JP2015524327A 2012-07-26 2013-07-18 外部寄生虫撲滅薬スピノサドを用いてネコを治療するための単回用量経口製剤および方法 Withdrawn JP2015523388A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676023P 2012-07-26 2012-07-26
US61/676,023 2012-07-26
PCT/US2013/050987 WO2014018352A1 (en) 2012-07-26 2013-07-18 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

Publications (2)

Publication Number Publication Date
JP2015523388A JP2015523388A (ja) 2015-08-13
JP2015523388A5 true JP2015523388A5 (cg-RX-API-DMAC7.html) 2016-09-08

Family

ID=48877579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015524327A Withdrawn JP2015523388A (ja) 2012-07-26 2013-07-18 外部寄生虫撲滅薬スピノサドを用いてネコを治療するための単回用量経口製剤および方法

Country Status (14)

Country Link
US (2) US9220719B2 (cg-RX-API-DMAC7.html)
EP (1) EP2877005A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015523388A (cg-RX-API-DMAC7.html)
KR (1) KR20150023831A (cg-RX-API-DMAC7.html)
CN (1) CN104703474A (cg-RX-API-DMAC7.html)
AR (1) AR091769A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013293350B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015001152A2 (cg-RX-API-DMAC7.html)
CA (1) CA2878009A1 (cg-RX-API-DMAC7.html)
EA (1) EA201590097A1 (cg-RX-API-DMAC7.html)
IN (1) IN2014MN02599A (cg-RX-API-DMAC7.html)
MX (1) MX2015001137A (cg-RX-API-DMAC7.html)
TW (1) TW201416077A (cg-RX-API-DMAC7.html)
WO (1) WO2014018352A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183512A1 (en) * 2017-03-28 2018-10-04 Piedmont Animal Health, Llc Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
WO2022271924A1 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011963A1 (en) 1999-08-12 2001-02-22 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
IL157974A0 (en) * 2001-03-21 2004-03-28 Dow Agrosciences Llc Pesticidal macrolides
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US20070149464A1 (en) * 2005-06-15 2007-06-28 Pfizer Inc. Combination
EP2248422A1 (en) * 2009-05-08 2010-11-10 Novartis AG Ectoparasiticidal compositions
US20120003661A1 (en) 2010-07-05 2012-01-05 C3 Jian, Inc. Methods and devices for the selective detection of microorganisms
JP2013542737A (ja) * 2010-11-05 2013-11-28 イーライ リリー アンド カンパニー 昆虫侵入を阻害するための方法

Similar Documents

Publication Publication Date Title
AU2014363599B2 (en) Orally disintegrating solid dosage unit containing an estetrol component
JP2015078230A5 (cg-RX-API-DMAC7.html)
HRP20150644T1 (hr) Metoda za lijeäśenje atrijalne fibrilacije
JP2015523407A5 (cg-RX-API-DMAC7.html)
JP2016540021A5 (cg-RX-API-DMAC7.html)
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
UY35624A (es) Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington
NZ711179A (en) Oral formulations of deferasirox
RU2016122609A (ru) Составы соединений азаиндола
JP2015524444A5 (cg-RX-API-DMAC7.html)
JP2015038135A5 (cg-RX-API-DMAC7.html)
RU2019134558A (ru) Композиции и способы лечения анемии
JP2015510916A5 (cg-RX-API-DMAC7.html)
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
ME02474B (me) Terapijski režimi
JP2014507475A5 (cg-RX-API-DMAC7.html)
JP2015523388A5 (cg-RX-API-DMAC7.html)
JP2018039810A5 (cg-RX-API-DMAC7.html)
JP2016505050A5 (cg-RX-API-DMAC7.html)
JP2015521647A5 (cg-RX-API-DMAC7.html)
JP2014058509A5 (cg-RX-API-DMAC7.html)
JP2017520619A5 (cg-RX-API-DMAC7.html)
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
HRP20251123T1 (hr) Ekopipam za liječenje touretteovog sindroma
JP2015500340A5 (cg-RX-API-DMAC7.html)